Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)

Overview of attention for article published in Orphanet Journal of Rare Diseases, October 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 54 publications that cite this research output.

54

The most recent citing publications are shown below. View all 54 publications that cite this research output on Dimensions.

Caregiver experiences and observations of intrathecal idursulfase-IT treatment in a phase 2/3 trial in pediatric patients with neuronopathic mucopolysaccharidosis II

Article in Orphanet Journal of Rare Diseases (March 2024)

Characterization of orthopedic manifestations in patients with mucopolysaccharidosis II using data from 15 years of the Hunter Outcome Survey

Article (November 2023)

Management of MPS-I using ERT: The Egyptian experience

Preprint in Research Square (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.